A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Blood-brain barrier (BBB) models are often used to investigate BBB function and screen brain-penetrating therapeutics, but it has been difficult to construct a human model that possesses an optimal BBB phenotype and is readily scalable. To address this challenge, we developed a human in vitro BBB model comprising brain microvascular endothelial cells (BMECs), pericytes, astrocytes and neurons derived from renewable cell sources. First, retinoic acid (RA) was used to substantially enhance BBB phenotypes in human pluripotent stem cell (hPSC)-derived BMECs, particularly through adherens junction, tight junction, and multidrug resistance protein regulation. RA-treated hPSC-derived BMECs were subsequently co-cultured with primary human brain pericytes and human astrocytes and neurons derived from human neural progenitor cells (NPCs) to yield a fully human BBB model that possessed significant tightness as measured by transendothelial electrical resistance (~5,000 Ωxcm(2)). Overall, this scalable human BBB model may enable a wide range of neuroscience studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Other studies have shown mixed results regarding the effect of pericytes or other supporting cell types on TEER of dhBMEC monolayers [20, 33, 36, 41, 52–54].”
From Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D (2019) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A perivascular origin for mesenchymal stem cells in multiple human organs
Crisan, M., Yap, S., Casteilla, L., Chen, C.-W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., et al. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.07.003 · Cited by 3,991
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Pericytes are required for blood–brain barrier integrity during embryogenesis
Daneman, R., Zhou, L., Kebede, A. A., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09513 · Cited by 2,128
Blood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
A Membrane Receptor for Retinol Binding Protein Mediates Cellular Uptake of Vitamin A
Kawaguchi, R., Yu, J., Honda, J., Hu, J., Whitelegge, J., Ping, P., Wiita, P., Bok, D., & Sun, H. (2007) · Science · doi:10.1126/science.1136244 · Cited by 836
Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Self-citationElectrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study.
Butt, A. M., Jones, H. C., & Abbott, N. J. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018243 · Cited by 775
A cell culture model of the blood-brain barrier.
Rubin, L. L., Hall, D. E., Porter, S., Barbu, K., Cannon, C., Horner, H. C., Janatpour, M., Liaw, C. W., Manning, K., & Morales, J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.6.1725 · Cited by 765
Cited by
Items 101–200 of 547
A dynamic perfusion based blood-brain barrier model for cytotoxicity testing and drug permeation
Elbakary, B., & Badhan, R. K. S. (2020) · Scientific Reports · doi:10.1038/s41598-020-60689-w · Cited by 76
Kuan, W., Bennett, N. K., He, X., Skepper, J. N., Martynyuk, N., Wijeyekoon, R., Moghe, P. V., Williams‐Gray, C. H., & Barker, R. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.09.003 · Cited by 77
iPSCs-based generation of vascular cells: reprogramming approaches and applications
Klein, D. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2730-7 · Cited by 76
“The addition of retinoic acid in differentiated endothelial cell cultures further upregulated expression levels of the mature endothelial cell marker VE-Cadherin and resulted in a significant increase in trans-endothelial electrical resistance to physiological values [64, 65].”
BackgroundHagan, N., & Ben‐Zvi, A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.12.006 · Cited by 74
Banerjee, J., Shi, Y., & Azevedo, H. S. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.05.020 · Cited by 74
Roux, G. L., Jarray, R., Guyot, A.-C., Pavoni, S., Costa, N., Théodoro, F., Nassor, F., Pruvost, A., Tournier, N., Kiyan, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52213-6 · Cited by 74
Patel, R., Page, S., & Al‐Ahmad, A. J. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14040 · Cited by 64
Self-citationKulczar, C. D., Lubin, K. E., Lefebvre, S., Miller, D. W., & Knipp, G. T. (2017) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12803 · Cited by 71
“Rhodamine 123 is a known P-gp substrate and is often used to determine functional expression of P-gp in BMEC cell lines.([8,17,60,61]) Verapamil was used as a P-gp inhibitor to show the difference in total cellular accumulation of rhodamine 123 in its presence.”
MethodKatt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 71
An isogenic hiPSC-derived BBB-on-a-chip
Motallebnejad, P., Thomas, A., Swisher, S. L., & Azarin, S. M. (2019) · Biomicrofluidics · doi:10.1063/1.5123476 · Cited by 71
Self-citationRetinoic acid ameliorates blood–brain barrier disruption following ischemic stroke in rats
Kong, L., Wang, Y., Wang, X., Wang, X., Zhao, Y., Wang, L., & Chen, Z.-Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.05.014 · Cited by 71
Wasielewska, J. M., & White, A. R. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03185-2 · Cited by 69
Wilson, H. K., Canfield, S. G., Shusta, E. V., & Palecek, S. P. (2014) · Stem Cells · doi:10.1002/stem.1797 · Cited by 69
Self-citationOhshima, M., Kamei, S., Fushimi, H., Mima, S., Yamada, T., & Yamamoto, T. (2019) · BioResearch open access · doi:10.1089/biores.2019.0026 · Cited by 69
In vitro screening of nanomedicines through the blood brain barrier: A critical review
Aparicio-Blanco, J., Martín‐Sabroso, C., & Torres‐Suárez, A. I. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.051 · Cited by 69
“Likewise, all other cellular elements of the neurovascular unit could be obtained with appropriate differentiation processes [247].”
BackgroundKurosawa, T., Tega, Y., Higuchi, K., Yamaguchi, T., Nakakura, T., Mochizuki, T., Kusuhara, H., Kawabata, K., & Deguchi, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00697 · Cited by 69
Ito, R., Umehara, K., Suzuki, S., Kitamura, K., Nunoya, K., Yamaura, Y., Imawaka, H., Izumi, S., Wakayama, N., Komori, T., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00519 · Cited by 70
Linville, R. M., Sklar, M. B., Grifno, G. N., Nerenberg, R. F., Zhou, J., Ye, R., DeStefano, J. G., Guo, Z., Jha, R., Jamieson, J. J., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00377-1 · Cited by 67
“We reproduced iBMEC differentiation protocols [19, 22] across three isogenic cell lines with fluorescently-labeled ZO1 (iBMEC-TJs), plasma membrane (iBMEC-PMs), and β-actin (iBMEC-ACTBs) (Fig.”
MethodResultKim, B. J., Bee, O. B., McDonagh, M. A., Stebbins, M. J., Palecek, S. P., Doran, K. S., & Shusta, E. V. (2017) · mSphere · doi:10.1128/msphere.00398-17 · Cited by 67
“The addition of retinoic acid during BMEC differentiation has been shown to elevate BBB properties, including TEER and vascular endothelial (VE)-cadherin expression (38, 39).”
Self-citationGomes, S. F. M., Westermann, A. J., Sauerwein, T., Hertlein, T., Förstner, K. U., Ohlsen, K., Metzger, M., Shusta, E. V., Kim, B. J., Appelt‐Menzel, A., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01181 · Cited by 66
Self-citationPraça, C., Rosa, S. C., Sevin, E., Cecchelli, R., Dehouck, M., & Ferreira, L. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.002 · Cited by 66
“, 2012) and RA (Katt et al., 2016; Lippmann et al., 2014) signaling was necessary for the specification of BBB properties in ECs.”
BackgroundAl-Ahmad, A. J., Patel, R., Palecek, S. P., & Shusta, E. V. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18767748 · Cited by 59
“Neural progenitor cells (NPCs) co-differentiating with BMECs have shown pivotal roles inducing a barrier phenotype, through signaling pathways such as Wnt/b-catenin and retinoic acid pathways.(24,27,56) We cannot exclude that the presence of HA or oHA may disrupt the maturation of both BMECs and NPCs during the time-w…”
Self-citationStroke-induced damage on the blood–brain barrier
Xue, S., Zhou, X., Yang, Z., Si, X., & Sun, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1248970 · Cited by 64
“Lippmann’s study showed that endothelial cells with barrier properties can be generated from human pluripotent stem cells (246, 247).”
Ruano-Salguero, J. S., & Lee, K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-60438-z · Cited by 56
Curtaz, C. J., Schmitt, C., Herbert, S.-L., Feldheim, J., Schlegel, N., Gosselet, F., Hagemann, C., Roewer, N., Meybohm, P., Wöckel, A., et al. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00192-6 · Cited by 65
Zhou, Y., Zhang, H., Zheng, B., Ye, L., Zhu, S., Johnson, N. R., Wang, Z., Wei, X., Chen, D., Cao, G., et al. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13229 · Cited by 63
“ECs form a tight structural barrier due to the presence of well-developed tight junction (TJ) proteins on the luminal side of the endothelium that ef- Int.”
BackgroundInfluentialYan, L., Moriarty, R. A., & Stroka, K. M. (2021) · Theranostics · doi:10.7150/thno.63195 · Cited by 62
“Wang et al. cocultured UM-RA BMEC-like cells with rat primary astrocytes in a BBB-on-chip model with integrated TEER electrodes.”
BackgroundMethodInfluentialGonzales‐Aloy, E., Ahmed-Cox, A., Tsoli, M., Ziegler, D. S., & Kavallaris, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114777 · Cited by 61
Blood-brain barrier modeling: challenges and perspectives
Ruck, T., Bittner, S., & Meuth, S. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.158342 · Cited by 60
“Cell-based approaches enable simplified, cost effective, highly flexible and easy controllable in vitro models of the BBB. Endothelial cells can be tapped from many different sources such as human or rodent brain tissue or cell-line- and stem-cell-derivatives (Lippmann et al., 2014).”
BackgroundInfluentialEngineered nanoparticles for systemic siRNA delivery to malignant brain tumours
Karlsson, J. E., Rui, Y., Kozielski, K., Placone, A. L., Choi, O., Tzeng, S. Y., Kim, J., Keyes, J. J., Bogorad, M. I., Gabrielson, K. L., et al. (2019) · Nanoscale · doi:10.1039/c9nr04795f · Cited by 60
Hudecz, D., Khire, T., Chung, H. L., Adumeau, L., Glavin, D., Luke, E., Nielsen, M. S., Dawson, K. A., McGrath, J. L., & Yan, Y. (2020) · ACS Nano · doi:10.1021/acsnano.9b08870 · Cited by 54
Drug Delivery to the Brain: Physiological Concepts, Methodologies, and Approaches
Samala, R., Noorani, B., Thorsheim, H. R., Bickel, U., & Smith, Q. R. (2022) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-030-88773-5_10 · Cited by 59
Lee, H., Aylward, A. J., Pearse, R. V., Lish, A. M., Hsieh, Y.-C., Augur, Z. M., Benoit, C. R., Chou, V., Knupp, A., Pan, C., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112994 · Cited by 58
Urbanczyk, M., Zbinden, A., & Schenke‐Layland, K. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114323 · Cited by 58
Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells: Current Controversies
Lu, T. M., Durán, J. G. B., Houghton, S., Rafii, S., Redmond, D., & Lis, R. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.642812 · Cited by 58
The Isolated Brain Microvessel: A Versatile Experimental Model of the Blood-Brain Barrier
Pardridge, W. M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00398 · Cited by 50
Appelt‐Menzel, A., Oerter, S., Mathew, S., Haferkamp, U., Hartmann, C., Jung, M., Neuhaus, W., & Pleß, O. (2020) · Current Protocols in Stem Cell Biology · doi:10.1002/cpsc.122 · Cited by 57
Gliotoxin penetrates and impairs the integrity of the human blood-brain barrier in vitro
Patel, R., Hossain, M. A., German, N., & Al-Ahmad, A. J. (2018) · Mycotoxin Research · doi:10.1007/s12550-018-0320-7 · Cited by 56
Self-citationPhysiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles
Islam, Y., Leach, A. G., Smith, J. A., Pluchino, S., Coxon, C. R., Sivakumaran, M., Downing, J. E., Fatokun, A. A., Teixidò, M., & Ehtezazi, T. (2021) · Advanced Science · doi:10.1002/advs.202002085 · Cited by 57
Stebbins, M. J., Lippmann, E. S., Faubion, M. G., Daneman, R., Palecek, S. P., & Shusta, E. V. (2018) · Biotechnology Journal · doi:10.1002/biot.201700093 · Cited by 47
“Neither RA nor retinoid receptor agonists elevated occludin levels, contrasting with previous observations of RAmediated increases in occludin expression in hPSC-derived BMECs and hCMECs treated with RA [10, 14].”
BackgroundMethodSelf-citationMohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.002 · Cited by 53
“After 2 days of culture, inserts then were placed on top of the astrocyte layer and incubated for 72 h at 37 °C. Human iPS-derived ECs were used between passages 2 and 5 (Lippmann et al., 2014).”
Wan, J., Zhou, S., Mea, H. J., Guo, Y., Ku, H., & Urbina, B. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00480 · Cited by 54
Choi, J.-W., Seo, M., Kim, K., Kim, A.-R., Lee, H., Kim, H.-S., Park, C. G., Cho, S. W., Kang, J. H., Joo, J., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c11675 · Cited by 53
Furihata, T., Kawamatsu, S., Ito, R., Saito, K., Suzuki, S., Kishida, S., Saito, Y., Kamiichi, A., & Chiba, K. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0003-0 · Cited by 53
In Vitro Models for Studying Transport Across Epithelial Tissue Barriers
Arumugasaamy, N., Navarro, J., Leach, J. K., Kim, P. C. W., & Fisher, J. P. (2018) · Annals of Biomedical Engineering · doi:10.1007/s10439-018-02124-w · Cited by 53
Review of Design Considerations for Brain-on-a-Chip Models
Cameron, T., Bennet, T. J., Rowe, E. M., Anwer, M., Wellington, C. L., & Cheung, K. C. (2021) · Micromachines · doi:10.3390/mi12040441 · Cited by 54
“The reinforcing effect of pericytes on in vitro BBB integrity has also been observed by many groups with various cell sources [37,88,149,150].”
BackgroundLee, C. A. A., Seo, H. S., Armien, A. G., Bates, F. S., Tolar, J., & Azarin, S. M. (2018) · Fluids and Barriers of the CNS · doi:10.1186/s12987-018-0094-5 · Cited by 52
“iBMECs from this system are readily renewable and have been shown to recapitulate important BMEC properties such as junctional protein expression, formation of a tight barrier with physiologically relevant trans-endothelial electrical resistance (TEER) (~ 5000 Ω cm2), and multidrug resistance protein efflux activity […”
BackgroundSelf-citationKoenig, L., Ramme, A. P., Faust, D., Mayer, M., Flötke, T., Gerhartl, A., Brachner, A., Neuhaus, W., Appelt‐Menzel, A., Metzger, M., et al. (2022) · Cells · doi:10.3390/cells11203295 · Cited by 52
“Neural spheroids were differentiated from the iPSC line HUMIMIC101 [17] and combined in a 96-well Transwell model with brain microvascular endothelial (BMEC)-like cells [1] derived from the same donor.”
MethodPatel, R., & Alahmad, A. J. (2016) · Fluids and Barriers of the CNS · doi:10.1186/s12987-016-0030-5 · Cited by 48
“2c); all three proteins were detected in our monolayers and this was consistent with the existing literature [7, 8, 11].”
BackgroundMethodResultInfluentialSelf-citationMantle, J. L., & Lee, K. H. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.030 · Cited by 50
Minami, H., Tashiro, K., Okada, A., Hirata, N., Yamaguchi, T., Takayama, K., Mizuguchi, H., & Kawabata, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0128890 · Cited by 42
“showed that BMEC-like cells could be generated from human PSCs by spontaneous differentiation cultures [24,25].”
BackgroundAll Together Now: Modeling the Interaction of Neural With Non-neural Systems Using Organoid Models
Chukwurah, E., Osmundsen, A. M., Davis, S. W., & Lizarraga, S. B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00582 · Cited by 51
β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function
Ziegler, N., Awwad, K., Fißlthaler, B., Reis, M., Devraj, K., Corada, M., Minardi, S. P., Dejana, E., Plate, K. H., Fleming, I., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0148-16.2016 · Cited by 51
“Because of its strong expression in CNS vessels, the function of Cyp1b1 in metabolizing RA from RO could be of importance given the emerging role of RA in BBB formation (Chambers et al., 2007; Mizee et al., 2013; Lippmann et al., 2014).”
BackgroundEngineering brain-on-a-chip platforms
Servais, B., Mahmoudi, N., Gautam, V., Tong, W., Ibbotson, M. R., Nisbet, D. R., & Collins, D. J. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00184-3 · Cited by 50
“However, to fully understand the functioning of neurons and neural networks, it is necessary to record the electrical activity of individual neurons and their intercellular or network communication 10,13,15 .”
Validation of an immortalized human (hBMEC) in vitro blood-brain barrier model
Eigenmann, D. E., Jähne, E. A., Smieško, M., Hamburger, M. O., & Oufir, M. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9313-6 · Cited by 50
“RA had been previously found to increase TEER values in a human stem cell-based BBB model [32], and puromycin was reported to decrease the permeability of”
BackgroundMorphogens and blood-brain barrier function in health and disease
Wevers, N. R., & de Vries, H. E. (2015) · Tissue Barriers · doi:10.1080/21688370.2015.1090524 · Cited by 49
“Similar effects were described using brain microvascular endothelial cells derived from human pluripotent stem cells (hPSCs), indicating that RA is a potent stimulator of BBB function.(50) Several studies have shown aberrant RA signaling in the brains of AD patients.”
BackgroundPaving the Way Toward Complex Blood-Brain Barrier Models Using Pluripotent Stem Cells
Lauschke, K., Frederiksen, L., & Hall, V. J. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0003 · Cited by 49
“However, the isogenic coculture model did not include pericytes, which might increase the TEER values, as previously presented in the model with pericyte priming (up to 5,000 Ocm(2)) [43].”
InfluentialOrgan-On-A-Chip Technologies for Advanced Blood–Retinal Barrier Models
Ragelle, H., Gonçalves, A., Kustermann, S., Antonetti, D. A., & Jayagopal, A. (2020) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2019.0017 · Cited by 49
Choi, J.-W., Youn, J., Kim, D. S., & Park, T. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121983 · Cited by 48
Strategies for derivation of endothelial lineages from human stem cells
Xu, M., He, J., Zhang, C., Xu, J., & Wang, Y. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-019-1274-1 · Cited by 48
“, activin A, BMP4, bFGF, CHIR, and BIO) [37, 38, 51–56], some other growth factors (such as VEGF-A, SB431542, and retinoic acid) [26, 39, 49], or their combinations [57] and agonists of signaling pathways [58].”
BackgroundAdvanced Human BBB‐on‐a‐Chip: A New Platform for Alzheimer's Disease Studies
Yoon, J., Kim, J., Shah, Z., Awasthi, A., Mahajan, A., & Kim, Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002285 · Cited by 49
Sun, J., Ou, W., Han, D., Paganini-Hill, A., Fisher, M. J., & Sumbria, R. K. (2022) · PLOS ONE · doi:10.1371/journal.pone.0268860 · Cited by 47
“Based on published reports, our ihBMEC culturing protocol uses retinoic acid to enhance the TEER [45].”
MethodMicrophysiological systems for recapitulating physiology and function of blood-brain barrier
Seo, S., Kim, H., Sung, J. H., Choi, N., Lee, K., & Kim, H. N. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119732 · Cited by 47
Yamashita, M., Aoki, H., Hashita, T., Iwao, T., & Matsunaga, T. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00197-1 · Cited by 47
Wellens, S., Dehouck, L., Chandrasekaran, V., Singh, P., Loiola, R. A., Sevin, E., Exner, T. E., Jennings, P., Gosselet, F., & Culot, M. (2021) · Toxicology in Vitro · doi:10.1016/j.tiv.2021.105112 · Cited by 46
Kennedy, C. C., Brown, E., Abutaleb, N. O., & Truskey, G. A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.625016 · Cited by 46
“Additionally, the permeability barrier of these human iPSC-BMVECs exhibit TEER values at physiological levels (72, 74).”
BackgroundRetinoic acid signaling in vascular development
Pawlikowski, B. T., Wragge, J., & Siegenthaler, J. A. (2019) · genesis · doi:10.1002/dvg.23287 · Cited by 45
A Quasi-Physiological Microfluidic Blood-Brain Barrier Model for Brain Permeability Studies
Noorani, B., Bhalerao, A., Raut, S., Nozohouri, E., Bickel, U., & Cucullo, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091474 · Cited by 45
“Accordingly, numerous reports have demonstrated that iBMECs possess active efflux activity as determined by substrate inhibition assays [19,21,29,37].”
BackgroundMethodInfluentialChen, L., Sutharsan, R., Lee, J. L., Cruz, E., Asnicar, B., Palliyaguru, T., Wasielewska, J. M., Gaudin, A., Song, J. H., Leinenga, G., et al. (2022) · Theranostics · doi:10.7150/thno.65539 · Cited by 45
“In a co-culture system with human induced pluripotent stem cell (hiPSC)-derived endothelial cells (iBECs) and neuronal progenitor cells treated with retinoic acid, TEER values up to 5,000 Ω·cm2 have been achieved [14].”
BackgroundBrown, J. A., Faley, S. L., Shi, Y., Hillgren, K. M., Sawada, G. A., Baker, T. K., Wikswo, J. P., & Lippmann, E. S. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00200-9 · Cited by 44
Self-citationRole of the neurovascular unit in the process of cerebral ischemic injury
Zhao, Y. S., Yang, J., Li, C., Zhou, G., Wan, H., Ding, Z., Wan, H., & Zhou, H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105103 · Cited by 45
Raut, S., Patel, R., & Al-Ahmad, A. J. (2021) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00235-y · Cited by 41
Self-citationKurosawa, T., Sako, D., Tega, Y., Debori, Y., Tomihara, Y., Aoyama, K., Kubo, Y., Amano, N., & Deguchi, Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03249-3 · Cited by 44
“hiPS cells into hiPS-BMECs was performed as previously reported (16, 17).”
MethodClark, P. A., Al-Ahmad, A. J., Qian, T., Zhang, R. R., Wilson, H. K., Weichert, J. P., Palecek, S. P., Kuo, J. S., & Shusta, E. V. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00441 · Cited by 43
Self-citationLab-on-a-chip models of the blood–brain barrier: evolution, problems, perspectives
Deli, M. A., Porkoláb, G., Kincses, A., Mészáros, M., Szecskó, A., Kocsis, A. E., Vigh, J. P., Valkai, S., Veszelka, S., Walter, F. R., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00996c · Cited by 43
Noorani, B., Chowdhury, E. A., Alqahtani, F., Ahn, Y., Patel, D., Al-Ahmad, A. J., Mehvar, R., & Bickel, U. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00224-1 · Cited by 42
Self-citationHuang, J., Li, Y. B., Charlebois, C., Nguyen, T., Liu, Z., Bloemberg, D., Zafer, A., Baumann, E., Sodja, C., Leclerc, S., et al. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00342-y · Cited by 43
Li, Y., Sun, X., Liu, H., Huang, L. J., Meng, G., Ding, Y., Su, W., Lu, J., Gong, S., Terstappen, G. C., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00384-7 · Cited by 41
Srinivasan, B., & Kolli, A. R. (2018) · Neuromethods · doi:10.1007/978-1-4939-8946-1_6 · Cited by 41
Diverse functions of retinoic acid in brain vascular development.
Bonney, S., Harrison-Uy, S., Mishra, S., MacPherson, A. M., Choe, Y., Li, D., Jaminet, S.-C., Fruttiger, M., Pleasure, S. J., & Siegenthaler, J. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3952-15.2016 · Cited by 40
“…(Lai et al., 2003; Bohnsack et al., 2004) and there is some evidence that it may have a role in angiogenesis and vessel maturation in the CNS. RA is implicated in BBB development through the regulation of BBB protein expression, specifically VE-cadherin (Mizee et al., 2013; Lippmann et al., 2014).”
BackgroundAl-Ahmad, A. J. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00116.2017 · Cited by 41
“iPSCs were differentiated into BMECs following the protocol established by Lippmann and colleagues (18, 19).”
MethodSelf-citationMarco, A. D., Vignone, D., Paz, O. G., Fini, I., Battista, M. R., Cellucci, A., Bracacel, E., Auciello, G., Veneziano, M., Khetarpal, V. K., et al. (2020) · Cells · doi:10.3390/cells9040994 · Cited by 40
“Recent scientific advances in stem cell research have opened new opportunities for in vitro disease modelling and stem cells have been explored to develop functional in vitro human BBB systems [5,6].”
BackgroundThe Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
Högberg, H. T., & Smirnova, L. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.808620 · Cited by 40
Fengler, S., Kurkowsky, B., Kaushalya, S. K., Roth, W., Fava, E., & Denner, P. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121525 · Cited by 40
Barberio, C., Withers, A. M., Mishra, Y., Couraud, P., Romero, I. A., Weksler, B. B., & Owens, R. M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1065193 · Cited by 40
“Co-culturing brain endothelial cells with the other types of NVU cells has been shown to improve BBB integrity in several studies (Gaillard et al., 2001; Boveri et al., 2005; Cucullo et al., 2008; Malina et al., 2009; Hatherell et al., 2011; Lippmann et al., 2014; Appelt-Menzel et al., 2017).”
Kokubu, Y., Yamaguchi, T., & Kawabata, K. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.092 · Cited by 40
Human iPSC application in Alzheimer’s disease and tau-related neurodegenerative diseases
TCW, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.043 · Cited by 39
Synergistic induction of blood–brain barrier properties
Porkoláb, G., Mészáros, M., Szecskó, A., Vigh, J. P., Walter, F. R., de Figueiredo, R. M., Kálomista, I., Hoyk, Z., Vizsnyiczai, G., Gróf, I., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316006121 · Cited by 40
Compounds Blocking Methylglyoxal-induced Protein Modification and Brain Endothelial Injury
Tóth, A. E., Tóth, A., Walter, F. R., Kiss, L., Veszelka, S., Ózsvári, B., Puskás, L. G., Heimesaat, M. M., Dohgu, S., Kataoka, Y., et al. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.10.009 · Cited by 38
Page, S., Raut, S., & Al-Ahmad, A. J. (2019) · NeuroMolecular Medicine · doi:10.1007/s12017-019-08531-z · Cited by 38
Self-citationVascularizing the brain in vitro
Aazmi, A., Zhou, H., Lv, W., Yu, M., Xu, X., Yang, H., Zhang, Y. S., & Ma, L. (2022) · iScience · doi:10.1016/j.isci.2022.104110 · Cited by 38
“This same protocol has been improved all along the years by the addition of retinoic acid during the differentiation process, which permitted the amelioration of the in vitro BBB functions to obtain a TEER value of around 5,350U cm2 under the co-culture condition (Lippmann et al., 2014).”
BackgroundMethodGama, C. S. D., & Morin‐Brureau, M. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.863836 · Cited by 38
“For example, the presence of retinoic acid during differentiation increases VE-cadherin expression and TEER (Lippmann et al., 2014).”
BackgroundMethodPiantino, M., Kang, D.-H., Furihata, T., Nakatani, N., Nakayama-Kitamura, K., Shigemoto‐Mogami, Y., Sato, K., & Matsusaki, M. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100324 · Cited by 38
Chen, L., Cruz, E., Oikari, L. E., Padmanabhan, P., Song, J. H., & Götz, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114517 · Cited by 38
Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells
Kim, B. J., McDonagh, M. A., Deng, L., Gastfriend, B. D., Schubert‐Unkmeir, A., Doran, K. S., & Shusta, E. V. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0146-5 · Cited by 38
Self-citationEndothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
Majewska, A., Wilkus, K., Brodaczewska, K. K., & Kiéda, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020520 · Cited by 37
Engdahl, E., van Schijndel, M. D. M., Voulgaris, D., Criscio, M. D., Ramsbottom, K. A., Rigden, D. J., Herland, A., & Rüegg, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115534 · Cited by 37
Inyang, E., Abhyankar, V. V., Chen, B., & Cho, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-59888-2 · Cited by 37
Blood brain barrier: A tissue engineered microfluidic chip
Musafargani, S., Mishra, S., Gulyás, M., Mahalakshmi, P., Archunan, G., Padmanabhan, P., & Gulyás, B. Z. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108525 · Cited by 36
Blood-Brain Barrier (BBB) Permeability and Transport Measurement In Vitro and In Vivo
Fu, B. M., Zhao, Z., & Zhu, D. (2020) · Methods in molecular biology · doi:10.1007/7651_2020_308 · Cited by 36
Metadata
- Authors
- Lippmann, E. S., Al-Ahmad, A., Azarin, S. M., Palecek, S. P., & Shusta, E. V.
- Affiliations
- University of Wisconsin–Madison (US)
- Corresponding author
- Palecek, Sean P.
- Shusta, Eric V.
- Venue
- Scientific Reports
- Published
- 2014-02-24
- Volume
- 4
- Issue
- 1
- Pages
- 4160-4160
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3932448
- OpenAlex
- W2042883482
- Cited by
- 508
- References
- 51
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 45 · 2023: 55 · 2022: 56 · 2021: 45 · 2020: 58 · 2019: 54 · 2018: 41 · 2017: 34 · 2016: 26 · 2015: 22 · 2014: 10
- FWCI
- 15.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Science Foundation (NS083688)
- Cedars-Sinai Medical Center
- Beijing Municipal Education Commission
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (AA020476, RC4AA020476)
- National Cancer Institute (P30CA014520)
- National Institute of General Medical Sciences (T32GM008505)
- National Institute of Neurological Disorders and Stroke (R01NS083688, NS083688)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Keywords
- blood-brain barrier model, retinoic acid, human pluripotent stem cells, brain microvascular endothelial cells, pericytes, astrocytes, neural progenitor cells, tight junctions, adherens junctions, multidrug resistance protein, transendothelial electrical resistance, co-culture
- MeSH terms
- Astrocytes, Blood-Brain Barrier, Brain, Cell Differentiation, Cells, Cultured, Electric Conductivity, Endothelium, Vascular, Humans, Models, Biological, Neurons, Tretinoin, Coculture Techniques, Pericytes, Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.